Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01709786 · ClinicalTrials.gov registry record
Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 88
- Enrollment target
NCT01709786: Completed study, sponsored by University of Cincinnati.
NCT01709786 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01709786 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
This study will evaluate the accuracy of two rapid methods of measuring hemoglobin in patients with suspected hemorrhage. These methods will be compared with standard laboratory measurements.
Primary Outcome
Whenever blood was drawn for laboratory measurement of serum hemoglobin, we used one drop of blood to make point-of-care measurements using the CDC and Radical-7 methods. For purposes of reporting outcomes measures, we took an equally weighted average of measurements on each device (i.e., all measurement occasions on all patients). These are the means reported in the Outcome Measures Data Table.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-12 |
What the finished NCT01709786 record still lists
NCT01709786 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01709786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01709786 about?
NCT01709786 is a clinical study titled "Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage". This study will evaluate the accuracy of two rapid methods of measuring hemoglobin in patients with suspected hemorrhage. These methods will be compared with standard laboratory measurements.
What is the current status of trial NCT01709786?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2012-09. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT01709786?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia